Kaplan-Meier-Plot comparing the outcome of MDS patients with elevated CIN values (red dashed line) and normal CIN values (blue solid line). After a median follow-up of 14.2 months, all but two patients in the “low CIN” group had stable disease, whereas all three patients with elevated CIN values reached the endpoint, defined as progression to AML or death.